Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Assets Average (2016 - 2025)

Medifast (MED) has disclosed Assets Average for 15 consecutive years, with $258.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 10.3% year-over-year to $258.1 million, compared with a TTM value of $258.1 million through Dec 2025, down 10.3%, and an annual FY2025 reading of $266.1 million, down 10.42% over the prior year.
  • Assets Average was $258.1 million for Q4 2025 at Medifast, down from $268.8 million in the prior quarter.
  • Across five years, Assets Average topped out at $409.9 million in Q1 2022 and bottomed at $258.1 million in Q4 2025.
  • Average Assets Average over 5 years is $319.3 million, with a median of $316.9 million recorded in 2023.
  • The sharpest move saw Assets Average skyrocketed 59.05% in 2021, then fell 22.19% in 2023.
  • Year by year, Assets Average stood at $384.8 million in 2021, then decreased by 16.52% to $321.3 million in 2022, then decreased by 1.97% to $315.0 million in 2023, then fell by 8.65% to $287.7 million in 2024, then dropped by 10.3% to $258.1 million in 2025.
  • Business Quant data shows Assets Average for MED at $258.1 million in Q4 2025, $268.8 million in Q3 2025, and $274.7 million in Q2 2025.